Neoadjuvant chemotherapy of invasive bladder cancer
A total of 40 chemonaive patients with invasive transitional cell carcinoma received gemcitabine 2 400 mg/m2 on days 1, 8 and 15 plus cisplatin 100 mg/m2 on day 2 as a presurgery treatment. Cisplatin in a single dose of 20 mg/m2 administered into pubic. Grade 3 hematologic toxicity was in 27,5% of p...
Saved in:
| Main Authors: | S. N. Isayeva, S. P. Selivanov, Ye. V. Udut, Т. А. Kovalik, T. I. Shabunina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2012-04-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/458 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
by: Takeshi Sasaki, et al.
Published: (2025-03-01) -
Efficacy and immunological effects of neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer
by: GAO Zhiqiang, CHEN Tao, LIU Lei, SUN Chunshan, JI Yilong, TANG Hao
Published: (2025-04-01) -
Bladder preservation by neoadjuvant chemotherapy followed
by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01) -
A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
by: Chinna Babu Dracham, et al.
Published: (2022-07-01) -
NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)